T FH in HIV Latency and as Sources of Replication-Competent Virus

Trends in Microbiology

Volumn 24, Issue 5, 2016, Pages 338-344

  Miles, Brodie ^a   Connick, Elizabeth ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Follicular dendritic cell; HIV 1; Latency; T follicular helper cells

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; FC RECEPTOR; INTERLEUKIN 21; PROTEIN BCL 6; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL EXPANSION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FOLLICULAR DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T CELL DEPLETION; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; T-LYMPHOCYTES, HELPER-INDUCER; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84959423239     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.02.006     Document Type: Review

References (78)

1. Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity 2014, 41:529-542.
2. Folkvord J.M., et al. Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms. AIDS Res. Hum. Retroviruses 2005, 21:363-370.
3. Perreau M., et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exper. Med. 2013, 210:143-156.
4. Connick E., et al. CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J. Immunol. 2007, 178:6975-6983.
5. + T cells are an important site of HIV replication in vivo. AIDS 1997, 11:849-857.
6. Connick E., et al. Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL. J. Immunol. 2014, 193:5613-5625.
7. + T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. Blood 2012, 120:4172-4181.
8. + T cells. J. Virol. 2009, 83:150-158.
9. Kohler S.L., et al. Germinal center t follicular helper cells (GC Tfh) are highly permissive to HIV-1 and alter their phenotype during virus replication. J. Immunol. 2016, Published online February 12, 2016. 10.4049/jimmunol.1502174.
10. Allam A., et al. TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1. Sci. Rep. 2015, 5:e10443.
11. + T-helper cells. Am. J. Pathol. 1992, 140:15.
12. Haase A.T., et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996, 274:985-989.
13. Heath S.L., et al. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995, 377:740-744.
14. van Nierop K., de Groot C. Human follicular dendritic cells: function, origin and development. Semin. Immunol. 2002, 14:251-257.
15. Schacker T., et al. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J. Infect Dis. 2000, 181:354-357.
16. Keele B.F., et al. Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J. Virol. 2008, 82:5548-5561.
17. + cells in the GI tract of SIV infected Rhesus macaques. Retrovirology 2010, 7:12.
18. Fukazawa Y., et al. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat. Med. 2015, 21:132-139.
19. Lindqvist M., et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J. Clin. Invest. 2012, 122:3271.
20. Petrovas C., et al. CD4 T follicular helper cell dynamics during SIV infection. J. Clin. Invest. 2012, 122:3281.
21. + T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J. Immunol. 2012, 188:3247-3256.
22. Choi Y.S., et al. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J. Immunol. 2013, 190:4014-4026.
23. Baumjohann D., et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 2013, 38:596-605.
24. Moir S., et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exper. Med. 2000, 192:637-646.
25. Boswell K.L., et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog. 2014, 10:e1003853.
26. Xu H., et al. Persistent Simian immunodeficiency virus infection causes ultimate depletion of follicular Th cells in AIDS. J. Immunol. 2015, 195:4351-4357.
27. Pantaleo G., et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-358.
28. Fan J., et al. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 1993, 151:5031-5040.
29. Nakajima K., et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J. Immunol. 1989, 142:531-536.
30. Harari A., et al. Analysis of HIV-1-and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002, 100:1381-1387.
31. Chowdhury A., et al. Decreased T follicular regulatory cell/T follicular helper cell (TFH) in simian immunodeficiency virus-infected rhesus macaques may contribute to accumulation of TFH in chronic infection. J. Immunol. 2015, 195:3237-3247.
32. Blackburn M.J., et al. Regulatory and helper follicular T cells and antibody avidity to simian immunodeficiency virus glycoprotein 120. J. Immunol. 2015, 195:3227-3236.
33. Miles B., et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat. Commun. 2015, 6:8608.
34. Colineau L., et al. HIV-infected spleens present altered follicular helper T cell (Tfh) subsets and skewed B cell maturation. PLoS ONE 2015, 10:e0140978.
35. Haas M.K., et al. Distinct patterns of Bcl-2 expression occur in R5-and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo. AIDS Res. Hum. Retroviruses 2015, 31:298-304.
36. Cubas R.A., et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat. Med. 2013, 19:494-499.
37. + T cells represent peripheral Tfh Cells with antigen-dependent helper functions. Immunity 2016, 44:167-178.
38. Chun T-W., et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13193-13197.
39. Finzi D., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
40. Wong J.K., et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
41. DeMaster L.K., et al. A subset of CD4/CD8 double negative T cells expresses HIV proteins in patients on ART. J. Virol. 2015, Published online November 4, 2015. 10.1128/JVI.01913-15.
42. Zhang L., et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 1999, 340:1605-1613.
43. Horiike M., et al. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology 2012, 423:107-118.
44. Rothenberger M.K., et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E1126-E1134.
45. Fletcher C.V., et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:2307-2312.
46. Günthard H.F., et al. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 1998, 72:2422-2428.
47. Nettles R.E., et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA 2005, 293:817-829.
48. von Stockenstrom S., et al. Longitudinal genetic characterization reveals that cell proliferation maintains persistent HIV-1 during effective HIV therapy. J. Infect. Dis. 2015, 212:596-607.
49. Hermankova M., et al. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA 2001, 286:196-207.
50. Chomont N., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 2009, 15:893-900.
51. Hale J.S., Ahmed R. Memory T follicular helper CD4 T cells. Front. Immunol. 2015, 6:16.
52. Baron B.W., et al. BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region. Genes Chromosomes Cancer 1997, 19:14-21.
53. Kaczmarek K., et al. T cell transcription factors and their impact on HIV expression. Virology Res. Treatm. 2013, 2013:41.
54. Pallikkuth S., et al. Peripheral T follicular helper cells are the major HIV reservoir within central memory CD4 T cells in peripheral blood from chronic HIV infected individuals on cART. J. Virol. 2015, Published online December 16, 2015. 10.1128/JVI. 02883-15.
55. Chahroudi A., Silvestri G. HIV and Tfh cells: circulating new ideas to identify and protect. Immunity 2016, 44:16-18.
56. Rodriguez-Barradas M.C., et al. Quantitative and qualitative antibody responses to immunization with the pneumococcal polysaccharide vaccine in HIV-Infected patients after initiation of antiretroviral treatment: results from a randomized clinical trial. J. Infect. Dis. 2014, 211:1703-1711.
57. Sepako E., et al. Incomplete recovery of pneumococcal CD4 T cell immunity after initiation of antiretroviral therapy in HIV-infected malawian adults. PLoS ONE 2014, 9:e100640.
58. Pallikkuth S., et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 2012, 120:985-993.
59. Cavert W., et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
60. Smith B.A., et al. Persistence of infectious HIV on follicular dendritic cells. J. Immunol. 2001, 166:690-696.
61. Hütter G., et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 2009, 360:692-698.
62. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med. 1999, 5:651-655.
63. Prins J.M., et al. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. AIDS 1999, 13:2405-2410.
64. Davey R.T., et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:15109-15114.
65. Archin N., et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 2012, 487:482-485.
66. Rasmussen T.A., et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. Lancet HIV 2014, 1:e13-e21.
67. Elliott J.H., et al. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. PLoS Pathog. 2014, 10:e1004473.
68. Routy J., et al. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV Med. 2012, 13:291-296.
69. Shan L., et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 2012, 36:491-501.
70. Skinner P., Connick E. Overcoming the immune privilege of B cell follicles to cure HIV-1 infection. J. Hum. Virol. Retrovirol. 2014, 1:1-3.
71. Halper-Stromberg A., et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 2014, 158:989-999.
72. Karpel M.E., et al. BLT humanized mice as a small animal model of HIV infection. Curr. Opin. Virol. 2015, 13:75-80.
73. Henrich T.J., et al. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann. Intern. Med. 2014, 161:319-327.
74. Cillo A.R., et al. Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J. Acquir. Immune Defic. Syndr. 2013, 63:438-441.
75. Mavigner M., et al. Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant. PLoS Pathog. 2014, 10:e1004406.
76. + T cells. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:12139-12144.
77. Santangelo P.J., et al. Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat. Meth. 2015, 12:427-432.
78. Hellmuth J., et al. CNS reservoirs for HIV: implications for eradication. J. Virus Erad. 2015, 1:67.